← Leaderboards
Lizbeth K. Hedstrom
Brandeis University
$19,004,997
Attributed
$19,004,997
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$19,004,997 · 11
By mechanism
R01$14,363,051 · 4
U01$3,292,498 · 1
R21$1,322,957 · 3
R13$15,500 · 2
P41$10,991 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsDesignPharmaceutical PreparationsEnzymesGuanine NucleotidesBaseDrug DiscoveryEventSmall MoleculeInosine MonophosphateActive SitesInfectionToxic EffectChemotherapyPathway InteractionsInhibitor/AntagonistMalignant NeoplasmsLigandsResearch StudyCancer TherapyCellsAnimal ModelIn VitroPrograms
Grant awards (47)
Ubiquitin-independent targeted protein degradation$691,634
R01 · FY2024 · GM · contact PI
Ubiquitin-independent targeted protein degradation$691,634
R01 · FY2023 · GM · contact PI
Ubiquitin-independent targeted protein degradation$116,990
R01 · FY2023 · GM · contact PI
Ubiquitin-independent targeted protein degradation$12,014
R01 · FY2023 · GM · contact PI
Ubiquitin-independent targeted protein degradation$691,634
R01 · FY2022 · GM · contact PI
2022 & 2024 Drug Resistance Gordon Research Conference and Seminar$5,500
R13 · FY2022 · AI · contact PI
Ubiquitin-independent targeted protein degradation$693,785
R01 · FY2021 · GM · contact PI
Ubiquitin-independent targeted protein degradation$741,798
R01 · FY2020 · GM · contact PI
Opportunities for multi-target drug discovery in tuberculosis$242,770
R21 · FY2020 · AI · contact PI
Inhibition of mTOR by a small molecule activator of TSC2$242,562
R21 · FY2020 · AG · contact PI
Inhibition of mTOR by a small molecule activator of TSC2$217,562
R21 · FY2019 · AG · contact PI
Opportunities for multi-target drug discovery in tuberculosis$202,145
R21 · FY2019 · AI · contact PI
IMP Dehydrogenase$324,411
R01 · FY2016 · GM · contact PI
IMPDH-targeted antibiotics for select agents$1,058,736
R01 · FY2015 · AI · contact PI
IMP Dehydrogenase$324,178
R01 · FY2015 · GM · contact PI
Inhibitor mediated protein degradation$308,354
R01 · FY2015 · GM · contact PI
IMPDH-targeted antibiotics for select agents$1,058,736
R01 · FY2014 · AI · contact PI
IMP Dehydrogenase$323,520
R01 · FY2014 · GM · contact PI
Inhibitor mediated protein degradation$307,404
R01 · FY2014 · GM · contact PI
IMPDH-targeted antibiotics for select agents$995,211
R01 · FY2013 · AI · contact PI
IMP Dehydrogenase$338,162
R01 · FY2013 · GM · contact PI
Inhibitor mediated protein degradation$293,450
R01 · FY2013 · GM · contact PI
IMPDH-targeted antibiotics for select agents$1,058,736
R01 · FY2012 · AI · contact PI
Inhibitor mediated protein degradation$303,085
R01 · FY2012 · GM · contact PI
IMPDH-targeted antibiotics for select agents$1,114,349
R01 · FY2011 · AI · contact PI
Development of IMPDH-Targeted Drugs against Crytosporidium$717,483
U01 · FY2010 · AI · contact PI
IMP Dehydrogenase$313,012
R01 · FY2010 · GM · contact PI
Development of IMPDH-Targeted Drugs against Crytosporidium$48,190
U01 · FY2010 · AI · contact PI
Development of IMPDH-Targeted Drugs against Crytosporidium$895,013
U01 · FY2009 · AI · contact PI
IMP Dehydrogenase$316,174
R01 · FY2009 · GM · contact PI
IMP Dehydrogenase$278,466
R01 · FY2009 · GM · contact PI
Enzymes, Coenzyme Metabolic Pathways Gordon Research Conference$4,000
R13 · FY2009 · GM · contact PI
Development of IMPDH-Targeted Drugs against Crytosporidium$770,714
U01 · FY2008 · AI · contact PI
IMP Dehydrogenase$315,068
R01 · FY2008 · GM · contact PI
Enzymes, Coenzyme Metabolic Pathways Gordon Research Conference$6,000
R13 · FY2008 · GM · contact PI
Development of IMPDH-Targeted Drugs against Crytosporidium$861,098
U01 · FY2007 · AI · contact PI
IMP Dehydrogenase$322,109
R01 · FY2007 · GM · contact PI
The mechanism of IMPDH1-mediated retinitis pigmentosa$186,918
R21 · FY2007 · EY · contact PI
The mechanism of IMPDH1-mediated retinitis pigmentosa$231,000
R21 · FY2006 · EY · contact PI
IMP Dehydrogenase$228,887
R01 · FY2006 · GM · contact PI
IMP Dehydrogenase$234,395
R01 · FY2005 · GM
IMP Dehydrogenase$258,633
R01 · FY2004 · GM
IMP Dehydrogenase$30,000
R01 · FY2004 · GM
FLAP REGION OF IMP DEHYDROGENASE$10,991
P41 · FY2004 · RR
Inosine Monophosphate Dehydrogenase$255,562
R01 · FY2003 · GM
INOSINE MONOPHOSPHATE DEHYDROGENASE$184,118
R01 · FY2001 · GM
INOSINE MONOPHOSPHATE DEHYDROGENASE$178,806
R01 · FY2000 · GM